PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
08-Dec-2025 Reid Waldman, M.D., Receives Entrepreneur of the Year Award for Visionary Work in Life Sciences Businesswire
08-Dec-2025 BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia Businesswire
08-Dec-2025 Orum Therapeutics Presents Preclinical Data at ASH 2025 Demonstrating Potent and Selective Antitumor Activity of ORM-1153, a CD123-Targeting Degrader Antibody Conjugate for Acute Myeloid Leukemia Businesswire
08-Dec-2025 Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease Businesswire
08-Dec-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
08-Dec-2025 Implementing CSA for GxP Systems Training Course: Transition, Documentation, and Post-Transition Challenges and Opportunities - ResearchAndMarkets.com Businesswire
08-Dec-2025 PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer Businesswire
08-Dec-2025 Kallyope Announces Positive Results from Phase 2b Study of Elismetrep for the Acute Treatment of Migraine Businesswire
08-Dec-2025 Riassunto: IBMI SNQ e ICHOM formano una partnership strategica in Asia, promuovendo l'assistenza sanitaria incentrata sul paziente nella regione Businesswire
08-Dec-2025 IBMI SNQ and ICHOM Forms Strategic Partnership in Asia, Advancing Patient-centered Healthcare in the Region Businesswire
08-Dec-2025 L’IBMI SNQ et l’ICHOM forment un partenariat stratégique en Asie afin de promouvoir les soins de santé centrés sur le patient dans la région Businesswire
08-Dec-2025 El SNQ del IBMI e ICHOM establecieron una alianza estratégica en Asia para promover la atención de salud centrada en el paciente en la región Businesswire
08-Dec-2025 IBMI SNQ und ICHOM gehen zur Förderung einer patientenorientierten Gesundheitsversorgung in der Region eine strategische Partnerschaft in Asien ein Businesswire
08-Dec-2025 IBMI SNQとICHOMがアジアで戦略的パートナーシップを締結し、患者中心のヘルスケア推進に向けた取り組みを促進 Businesswire
08-Dec-2025 Samenvatting: IBMI SNQ en ICHOM gaan strategisch partnerschap aan in Azië om patiëntgerichte gezondheidszorg in de regio te bevorderen Businesswire
08-Dec-2025 Sensorion Reports Independent Data Monitoring Committee Raises No Safety Concerns and Agrees to Continue SENS-501’s Audiogene Phase 1/2 Trial Businesswire
08-Dec-2025 Hercules Pharmaceuticals Approved as Authorized Distributor in Apexus 340B Prime Vendor Program Businesswire
08-Dec-2025 Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies Businesswire
07-Dec-2025 Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma Businesswire
07-Dec-2025 Star Therapeutics Presents Interim Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease, Demonstrating Substantial Bleed Reductions in All Patients, at ASH Annual Meeting Businesswire